Clinical trial

Study of M4344 in Combination With Niraparib

NCT04655183

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2020-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2020-12-01Date precision: day

Registry last updated2021-06-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Advanced Solid Tumorunresolved

Breast Cancerunresolved

Interventions

NiraparibDRUG · verified · RxNorm: niraparib

M4344DRUG

NiraparibDRUG · verified · RxNorm: niraparib

M4344DRUG

NiraparibDRUG · verified · RxNorm: niraparib

Sponsors & collaborators

EMD Serono Research & Development Institute, Inc.lead sponsor

Merck KGaA, Darmstadt, Germanycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04655183 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.